2013 annual financial data
Ultragenyx Pharmaceutical 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -32,280,000 USD and net income was -35,070,000 USD.
Operating cash flow was -31,200,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -32,280,000 USD
- Net income
- -35,070,000 USD
- Operating cash flow
- -31,200,000 USD